Last €323.62 EUR
Change Today -14.44 / -4.27%
Volume 94.0
RGO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Munich
As of 3:17 PM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - regeneron pharmaceuticals (RGO)

Name (Connections)Board RelationshipsTitleKey Developments
George Sing 17 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee 
Charles Baker J.D. 11 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 
Arthur Ryan 84 RelationshipsDirector, Member of Audit Committee and Member of Corporate Governance & Compliance Committee 

Compensation Committee* - regeneron pharmaceuticals (RGO)

Name (Connections)Board RelationshipsTitle
Charles Baker J.D. 11 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Joseph Goldstein M.D. 111 RelationshipsDirector, Member of Compensation Committee and Member of Technology Committee
Christine Poon 46 RelationshipsDirector, Member of Compensation Committee and Member of Corporate Governance & Compliance Committee
George Sing 17 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
Marc Tessier-Lavigne Ph.D. 83 RelationshipsDirector, Chairman of Compensation Committee and Member of Technology Committee
RGO Compensation vs. Industry
1.0M
360.7K
Chief Executive Officer
144.2K
266.3K
Chief Financial Officer
Share price activity for REGENERON PHARMACEUTICALS (RGO)
52 Week Price Performance
RGO
Industry Average

Corporate Governance Committee* - regeneron pharmaceuticals (RGO)

Name (Connections)Board RelationshipsTitle
Michael Brown M.D. 26 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Alfred Gilman M.D., Ph.D. 11 RelationshipsDirector, Member of Compensation Committee and Member of Technology Committee
Christine Poon 46 RelationshipsDirector, Member of Compensation Committee and Member of Corporate Governance & Compliance Committee
Arthur Ryan 84 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
RGO and Competitor
Insiders vs. External
Board
25%
75%
Regeneron Pharmaceuticals, Inc.
6%
94%
BioMarin Pharmaceutical Inc.
12%
88%
Vertex Pharmaceuticals Incorporated
18%
82%
Alexion Pharmaceuticals, Inc.
8%
92%
UCB S.A.
9%
91%
Jazz Pharmaceuticals Public Limited Company
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGO:GR €323.62 EUR -14.44

RGO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alexion Pharmaceuticals Inc $187.49 USD +5.52
BioMarin Pharmaceutical Inc $91.53 USD +3.35
Jazz Pharmaceuticals PLC $166.55 USD +1.22
UCB SA €64.23 EUR -1.05
Vertex Pharmaceuticals Inc $118.41 USD +3.26
View Industry Companies
 

Industry Analysis

RGO

Industry Average

Valuation RGO Industry Range
Price/Earnings 100.0x
Price/Sales 15.3x
Price/Book 15.8x
Price/Cash Flow 121.5x
TEV/Sales 14.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.